Company Analysis Applied DNA Sciences, Inc.
1. Summary
Advantages
- Price (3.08 $) is less than fair price (6.9 $)
- Current debt level 9.07% is below 100% and has decreased over 5 years from 43.35%.
Disadvantages
- Dividends (0%) are below the sector average (0.5442%).
- The stock's return over the last year (-98.55%) is lower than the sector average (-15.96%).
- The company's current efficiency (ROE=-200.9%) is lower than the sector average (ROE=9.61%)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Applied DNA Sciences, Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | 1% | -16.8% | 2.4% |
| 90 days | -80.7% | -20.8% | 9.6% |
| 1 year | -98.6% | -16% | 36% |
APDN vs Sector: Applied DNA Sciences, Inc. has significantly underperformed the "Healthcare" sector by -82.59% over the past year.
APDN vs Market: Applied DNA Sciences, Inc. has significantly underperformed the market by -134.51% over the past year.
Slightly volatile price: APDN is more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical deviations of about +/- 5-15% per week.
Long period: APDN with weekly volatility of -1.9% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (3.08 $) is lower than the fair price (6.9 $).
Price significantly below the fair price: The current price (3.08 $) is 124% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (0) is lower than that of the sector as a whole (48.77).
P/E vs Market: The company's P/E (0) is lower than that of the market as a whole (48.79).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (3.3) is lower than that of the sector as a whole (4.82).
P/BV vs Market: The company's P/BV (3.3) is lower than that of the market as a whole (3.36).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (1.2) is lower than that of the sector as a whole (33.76).
P/S vs Market: The company's P/S indicator (1.2) is lower than that of the market as a whole (10.23).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-0.9735) is higher than that of the sector as a whole (-22.15).
EV/Ebitda vs Market: The company's EV/Ebitda (-0.9735) is lower than that of the market as a whole (28.28).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -4.73% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-4.73%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (123.79%).
5.4. ROE
ROE vs Sector: The company's ROE (-200.9%) is lower than that of the sector as a whole (9.61%).
ROE vs Market: The company's ROE (-200.9%) is lower than that of the market as a whole (10.82%).
5.5. ROA
ROA vs Sector: The company's ROA (-72.86%) is lower than that of the sector as a whole (0.3443%).
ROA vs Market: The company's ROA (-72.86%) is lower than that of the market as a whole (6.51%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (7.63%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (10.79%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0.5442%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
